Modalities of the food intake-reducing effect of sibutramine in humans

Physiology and Behavior

Volumn 68, Issue 3, 2000, Pages 299-308

  Chapelot, Didier ^a   Marmonier, Corinne ^a   Thomas, Florence ^b   Hanotin, Corinne ^b  

^a UFR   (France)

^b Metabolism Therapeutic Division   (France)

Author keywords

Anorectic agent; Energy density; Energy intake reduction; Hunger ratings; Macronutrient specificity; Number of food items; Sibutramine; Visual analogue scales

Indexed keywords

PLACEBO; SIBUTRAMINE;

ADULT; ANOREXIA; APPETITE; ARTICLE; CALORIC INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; HUMAN EXPERIMENT; HUNGER; MALE; NEUROMODULATION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033956149     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(99)00176-6     Document Type: Article

References (54)

1. Long-term pharmacotherapy in the management of obesity. JAMA. 276:1996;1907-1915.
2. Davis W.M., Vansal S.S., Feller D.R. Advances and retreats in the pharmacotherapy of obesity. Drug Topics. 141:1997;114-121.
3. Buckett W.R., Thomas P.C., Luscombe G.P. The pharmacology of sibutramine hydrochloride (BTS 54524), a new antidepressant which induces rapid noradrenergic down-regulation. Prog Neuropsychopharmacol Biol Psychiay. 12:1988;575-584.
4. Gundlah C., Martin K.F., Heal D.J., Auerbach S.B. In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents. sibutramine is a reuptake inhibitor J Pharmacol Exp Ther. 283:1997;581-591.
5. Lean M.E.J. Sibutramine - a review of clinical efficacy. Int J Obes. 21:1997;S30-S36.
6. Luque C.A., Rey J.A., Fernandez A. Focus on sibutramine. a new anorectic agent for the treatment of obesity Formulary. 32:1997;1025-1039.
7. McNeely W.M., Goa K.L. Sibutramine. a review of its contribution to the management of obesity Grugs. 56:1998;1093-1124.
8. Bray G.A., Ryan D.H., Gordon D., Heidingsfelder S., Cerise F., Wilson K. A double-blind randomized placebo-controlled trial of sibutramine. Obes Res. 4:1996;263-270.
9. Hanotin C., Thomas F., Jones S.P., Leutenegger E., Drouin P. Efficacy and tolerability of sibutramine in obese patients. a dose-ranging study Int J Obes. 22:1998;32-38.
10. Jones S.P., Smiths I.G., Kelly F., Gray J.A. Long-term weight loss with sibutramine. Int J Obes. 19:1995;41.
11. Weintraub M., Rubio A., Golik A., Byrne L., Scheinbaum M. Sibutramine in weight control. a dose ranging, efficacy study Clin Pharmacol Ther. 50:1991;330-337.
12. Connoley L.P., Heal D.J., Stock M.J. A study in rats of the effects of sibutramine on food intake and thermogenesis. Br J Pharmacol. 141:1995;114-121.
13. Halford J.C.G., Heal D.J., Blundell J.E. Effects in the rat of sibutramine on food intake and the behavioral satiety sequence. Br J Pharmacol. 114:1995;387.
14. Rolls B.J., Shide D.J., Thorwart M.L., Ulbrecht J.S. Sibutramine reduces food intake in nondieting women with obesity. Obes Res. 6:1998;1-11.
15. Chapelot D., Pasquet P., Apfelbaum M., Fricker J. Cognitive factors in the dietary response of restrained and unrestrained eaters to manipulation of the fat content of a dish. Appetite. 25:1995;155-176.
16. Fricker J., Chapelot D., Pasquet P., Rozen R., Apfelbaum M. Effect of a covert fat dilution on the spontaneous food intake by lean and obese subjects. Appetite. 24:1995;121-138.
17. Fantino M., Souquet A.-M. Effects of metabolites 1 and 2 of sibutramine on the short-term control of food intake in the rat. Int J Obes. 19:1995;145.
18. Booth D., Mather P., Fuller J. Starch content of ordinary foods associatively condition human appetite and satiation, indexed by intake and eating pleasantness of starch-paired flavours. Appetite. 3:1982;163-184.
19. Rogers P.J., Blundell J.E. Effect of anorexic drugs on food intake and the micro-structure of eating in human subjects. Psychopharmacology (Berlin). 66:1979;159-165.
20. Stunkard A.J., Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition, and hunger. J Psychosom Res. 29:1985;71-83.
21. Garner D., Garfinkel P. The eating attitude test. an index of the symptoms of anorexia nervosa Psychol Med. 9:1979;273-279.
22. Kissileff H.R. Effects of physical state (liquid-solid) of foods on food intake. procedural and substantive contributions Am J Clin Nutr. 42;956-65:1985.
23. Garratt C.J., Hind I.D., Haddock H.E. Sibutramine metabolite kinetics in young and elderly subjects. J Clin Pharmacol. 35:1995;928.
24. Renaud S, Attie MC. La composition des aliments. INSERM 1989;U63. Bron.
25. Silverstone T., Stunkard A.J. The anorectic effect of dexamphetamine sulphate. Br J Pharmacol Chemother. 33:1968;513-522.
26. Hill A.J., Rogers P.J., Blundell J.E. Techniques for the experimental measurement of human eating behaviour. a practical guide Int J Obes. 19:1995;361-375.
27. Cole J.O., Levin A., Beake B., Kaiser P.E., Scheinbaum M.L. Sibutramine. A new weight loss agent without evidence of the abuse potential associated with amphetamines J Clin Psychopharmacol. 18:1998;231-236.
28. King D.J., Devaney N. Clinical pharmacology of sibutramine hydrochloride (BTS 54524), a new antidepressant, in healthy volunteers. Br J Clin Pharmacol. 26:1988;607-611.
29. Schofield W., Schofield C., James W.P.T. Basal metabolic rate - review and prediction, together with an annotated bibliography of source material. Hum Nutr Clin Nutr. 39C(Suppl. 1):1985;5-41.
30. Lawton C.L., Wales J.K., Hill A.J.et al. Serotoninergic manipulation, meal-induced satiety and eating pattern. effects of fluoxetine in obese female subjects Obes Res. 19:1995;361-375.
31. Shor-Posner G., Grinker G.A., Marinescu C., Brown O., Leibowitz S.F. Hypothalamic serotonin in the control of meal patterns and macronutrient selection. Brain Res Bull. 17:1986;663-671.
32. Wurtman J.J., Wurtman R.J. Fenfluramine and fluoxetine spare protein consumption while suppressing caloric intake by rats. Science. 198:1977;1178-1180.
33. Booth D.A. Conditioned satiety in the rat. J Comp Physiol Psychol. 81:1972;457-471.
34. Louis-Sylvestre J., Tournier A., Verger P., Chabert M., Delorme B., Hossenlopp J. Learned caloric adjustment of human intake. Appetite. 12:1989;95-103.
35. Blundell J.E., Halford J.C.G. Serotonin and appetite regulation. Implications for the pharmacological treatment of obesity. Pharmacol Pathophysiol. 6:1998;473-495.
36. Simansky K.J. Serotonergic control of the organisation of feeding and satiety. Behav Brain Res. 73:1996;37-42.
37. Stock M.J. Sibutramine. a review of the pharmacology of a novel anti-obesity agent Int J Obes. 21:1997;S25-S29.
38. Jackson H.C., Neeham A.M., Hutchins L.J., Mazurkiewicz S.E., Heal D.J. Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. Br J Pharmacol. 121:1997;1758-1762.
39. Stricker-Kongrad A., Souquet A.-M., Jackson H.C., Burlet C. Effects of various monoamine receptor antagonists on the decrease in food intake induced by sibutramine in the rat. Br J Pharmacol. 117:1996;167.
40. 1A receptor antagonist WAY100635. Int J Obes. 21:1998;S57.
41. Simansky K.J., Vaidyaa A.H. Behavioral mechanism for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats. comparison with directly acting 5-HT agonists Brain Res Bull. 25:1990;953-960.
42. Grignaschi G., Samanin R. Role of 5-HT receptors in the effect of d-fenfluramine on feeding pattern in the rat. Eur J Pharmacol. 212:1992;287-289.
43. 2 antagonists in rats. Psychopharmacology (Berlin) 1988;94:342-6.
44. Simansky K.J., Jabukow J., Sisk F.C., Vaidya A.H., Eberle-Wang K. Peripheral seotonin is an incomplete signal for eliciting satiety in sham-feeding rats. Pharmacol Biochem Behav. 43:1992;847-854.
45. Bloom S.R., Griffiths J., Finer N., Jones S.P., Romanec F.M. Effects of sibutramine on gut hormones in obese non-insulin dependent diabetics. Int J Obes. 20:1996;156.
46. 1A receptor in CCK-induced satiety in rats. Naunyn Schmiedebergs Arch Pharmacol. 351:1995;217-220.
47. Himaya A., Fantino M., Antoine J.M., Brondel L., Louis-Sylvestre J. Satiety power of dietary fat. a new appraisal Am J Clin Nutr. 65:1997;1410-1418.
48. Connoley I.P., Frost I., Heal D.J., Stock M.J. Role of β-adrenoreceptors in mediating the thermogenic effects of sibutramine. Br J Pharmacol. 117:1996;170.
49. Bray G.A., Nishizawa Y. Ventromedial hypothalamus modulates fat mobilization during fasting. Nature. 27:1978;900-902.
50. Jackson H.C., Bearham M.C., Mazurkiewicz S.E., Heal D.J., Buckett W.R. Investigations of the mechanism underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor sibutramine in the rat. Br J Pharmacol. 121:1997;1613-1618.
51. Hansen D.L., Toubro S., Macdonald I., Astrup A. The effect of sibutramine on sympathoadrenal activity in man. Int J Obes. 22:1998;S269.
52. Walsh K., Lean M.E.J. The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females with dyslipidaemia. Int J Obes. 22:1998;S269.
53. Stricker-Krongrad A., Souquet A.-M., Jackson H.C., Burlet C. Effects of sibutramine on feeding behaviour in dietary-induced obesity. role of dietary constituents Int J Obes. 19:1995;145.
54. Harris R.B., Zhou J., Redmann S.M., Smagin G.N., Smith S.R., Rodgers E., Zachwieja J.J. A leptin dose response study in obese (ob/ob) and lean (+/?) mice. Endocrinology. 139:1998;8-19.